Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: Comparison between the acute state and after remission

Polish Journal of Pharmacology

Volumn 52, Issue 3, 2000, Pages 237-241

  Kubera, Marta ^a   Kenis, Gunter ^b   Bosmans, Eugene ^b   Ziȩba, Andrzej ^c   Dudek, Dominika ^c   Nowak, Gabriel ^a,d   Maes, Michael ^e,f  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b Eurogenetics   (Belgium)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^e Clinical Research Center for Mental Health of Antwerp   (Belgium)

^f VANDERBILT UNIVERSITY   (United States)

Author keywords

Depression; Interleukin 1 receptor antagonist; Interleukin 10; Interleukin 6; Remission

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6;

BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; HUMAN; IMMUNE RESPONSE; RATING SCALE; REMISSION; REVIEW;

ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ANTIRHEUMATIC AGENTS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; REMISSION INDUCTION; SIALOGLYCOPROTEINS;

EID: 0033924970     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Darko D. F., Wilson N. W., Gillin J. C., Golshan S.: A critical appraisal of mitogen-induced lymphocyte proliferation in depressed patients. Amer. J. Psychiat., 1991, 148, 337-344.
2. Frommberger U. H., Bauer J., Haselbauer P., Fraulin A., Riemann D., Berger M.: Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiat. Clin. Neurosci., 1997, 247, 228-233.
3. Hamilton M.: A rating scale for depression. J. Neurol. Neurosurg. Psychiat., 1960, 23, 56-61.
4. Irwin M., Caldwell C., Smith T. L., Brown S., Schuckit M. A., Gillin J. C.: Major depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity. Arch. Gen. Psychiat., 1990, 47, 713-718.
5. Kubera M., Holan V., Basta-Kaim A., Roman A., Borycz J., Shani J. Effect of desipramine on immunological parameters in mice, and their reversal by stress. Int. J. Immunopharmacol., 1998, 20, 429-438.
6. Kubera M., Lin A-H., Kenis G., Bosmans E., van Bockstaele D., Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-γ/interleukin-10 production ratio. J. Clin. Psychopharmacol., in press.
7. Kubera M., Maes M., Holan V., Basta-Kaim A., Roman A., Shani J.: Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to chronic mild stress model of depression. J Affect. Disorders, in press.
8. Kubera M., Symbirtsev A., Basta-Kaim A., Borycz J., Roman A., Papp M., Claesson M.: Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol. J. Pharmacol., 1996, 48, 503-506.
9. Maes M., Bosmans E., De Joungh R., Kenis G., Vandoolaeghe E., Neels H.: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine, 1997, 9, 853-858.
10. Maes M., Bosmans E., Meltzer H. Y.: Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur. Arch. Psychiat. Clin. Neurosci., 1995, 245, 172-178.
11. Maes M., Bosmans E., Suy E., Minner B., Raus J.: Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process. Brit. J. Psychiat., 1989, 155, 793-798.
12. Maes M., Meltzer H. Y., Jacobs Y., Suy E., Calabrese J., Minner B., Raus J.: Autoimmunity in depression: higher phospholipid autoantibody titers. Acta Psychiat. Scand., 1993, 87, 160-166.
13. Maes M., Smith R., Scharpe S.: The monocyte-T-lymphocyte hypothesis of major depression Psychoneuroendocrinology, 1995, 49, 11-27.
14. Maes M., Song C., Lin A.-H., Bonaccorso S., Kenis G., de Jongh R., Bosmans E., Scharpe S.: Negative immunoregulatory effects of antidepressants: inhibition of interferon-y and stimulation of interleukin-10 secretion. Neuropsychopharmacology, 1999, 20, 370-379.
15. Maes M., Song C., Lin A., De Longh R., Van Gastel A., Kenis G. et al.: The effect of psychological stress on humans: increased production of pro-inflammatory cytokines and Th-1 like response in stress-induced anxiety. Cytokine, 1998, 10, 313-318.
16. Maes M., Vandoolaeghe E., Ranjan R., Bosmans E., Bergmans R., Desnyder R.: Increased serum interleukin-1-receptor-antagonist concentration in major depression. J. Affect. Disorders, 1995, 36, 29-36.
17. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., Kirchner H.: Cytokine production and serum proteins in depression. Scand. J. Immunol., 1995, 41, 534-538.
18. Służewska A., Rybakowski J., Bosmans E., Sobieska M., Berghmans R., Maes M., Wiktorowicz K.: Indicators of immune activation in major depression. Psychiat. Res., 1996, 64, 161-167.
19. Służewska A., Rybakowski J.K., Łaciak M., Mackiewicz A., Sobieska M, Wiktorowicz K.: Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. Acad. Sci, 1995, 762, 474-476.
20. Służewska A., Rybakowski J.K, Sobieska M., Bosmans E., Pollet H., Wiktorowicz K.: Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression. Depression, 1996, 39, 149-155.
21. Suzuki E., Shintani F., Kanba S., Asai M., Nakaki T.: Induction of interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain. Neurosci. Lett., 1996, 215, 201-204.
22. Xia Z., DePierre J., Nassberger L.: Tricyclic antidepressants inhibit IL-6, IL-1β, and TNF-α release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology, 1996, 34, 27-37.
23. Yirmiya R., Weidenfeld J., Pollak Y., Morag M., Morag A., Avitsur R., Baraqk O., Reichenberg A., Cohen E., Shavit Y., Ovadia H.: Cytokines, "depression due to a general medical condition", and antidepessant drugs. In: Cytokines, Stress, and Depression. Eds. Dantzer et al., Kluwer, Academic Plenum Publishers, New York, 1999.